XML 38 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands
9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net loss $ (19,929) $ (22,809)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 8,903 9,266
Stock-based compensation expense 5,572 8,228
Provision for doubtful accounts 63 1,957
Provision for product warranty 312 669
Loss from equity method investment 846 0
Change in fair value of financial instruments (1,417) (634)
Cost of financing instruments 0 322
Loss on disposal of equipment 0 89
Total non-cash adjustments 17,113 21,165
Changes in operating assets and liabilities:    
Accounts receivable 2,371 (1,033)
Inventory (398) (2,262)
Other assets (4,515) (208)
Accounts payable 825 2,218
Accrued expenses and other current liabilities 2,064 (2,302)
Total change in operating assets and liabilities 347 (3,587)
Net cash used in operating activities (2,469) (5,231)
Cash flows from investing activities:    
Purchase of equipment (3,274) (830)
Investment in patents (475) (524)
Proceeds from the sale of available-for-sale securities 0 150
Investments in an unconsolidated affiliate (12,000) 0
Consulting fees received related to unconsolidated affiliate 5,500 0
Purchase of a business (750) 0
Release (increase) of restricted cash (928) 1,246
Net cash provided by (used in) investing activities (11,927) 42
Cash flows from financing activities:    
Net proceeds from borrowings from credit facilities 3,786 600
Proceeds from private placement transaction 9,653 0
Net payments on short-term debt 0 (163)
Net proceeds from equity line of credit 0 1,980
Proceeds from stock plans 874 990
Payments on capital lease obligations (4) 0
Net cash provided by financing activities 14,309 3,407
Effect of foreign currency (1,028) 2,158
Net increase (decrease) in cash and cash equivalents (1,115) 376
Cash and cash equivalents at beginning of period 19,944 14,028
Cash and cash equivalents at end of period 18,829 14,404
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest 813 227
Cash paid during the period for income taxes 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Issuance of common stock under equity line of credit 0 228
Prior consulting fees received related to unconsolidated affiliate $ 3,000 $ 0